| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| AXSM | AXSM | Shares | USD | XNMS |
| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| AXSM | AXSM | Shares | USD | XNMS |
Axsome Therapeutics, Inc. develops treatments for central nervous system (CNS) conditions, including depression, agitation associated with Alzheimer's disease, migraine, narcolepsy, and fibromyalgia. The company is advancing a pipeline of products, including AXS-05, AXS-12, and AXS-14, aimed at addressing these conditions.
No recent RNS announcements for AXSM across AXSM.
No recent RNS announcements for AXSM across AXSM.